蒂莫辛的治疗应用:一个专利景观2018年至今
Michael Quagliata1, Anna Maria Papini1, Paolo Rovero2
1Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy.
Expert opinion on therapeutic patents
|December 22, 2023
概括
蒂莫辛是多功能治疗性,在免疫调节和抗癌治疗中具有应用. 分析最近的专利揭示了修改型蒂莫辛的机会,以提高稳定性和扩大治疗用途.
科学领域:
- 免疫学和治疗学.
- 对thymosins的治疗专利环境的分析.
背景情况:
- 胸腺素是小的胸腺衍生蛋白质,具有显著的免疫调节,血管生成和抗炎活性.
- 这些特性使得蒂莫辛在治疗眼睛疾病,癌症和免疫失调方面具有价值.
研究的目的:
- 分析2018年以后发布的基于蒂莫辛的治疗药物的专利格局.
- 根据胸腺素的功能和目标疾病对专利进行分类.
主要方法:
- 在Patentscope和Espacenet数据库中搜索了"thymosin".
- 专注于最初用英语撰写并在2018年后出版的专利.
- 分类专利根据治疗功能和疾病应用.
主要成果:
- 确定了基于蒂莫辛的治疗方法的关键专利.
- 突出提马尔法辛 (Zadaxin) 作为唯一经FDA批准的胸腺素药物.
- 在免疫学和抗癌疗法中证明了蒂莫辛的潜力.
结论:
- 蒂莫是有前途的治疗药物,特别是在免疫和癌症治疗中.
- 化学修饰可以提高蒂莫辛的稳定性,细胞透性和疗效.
- 开发更短的胆氨酸序列可以降低生产成本和时间.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


